Li Yuyan, Liu Xinhui, Liu Siqi, Lu Jiandong, Chen Jianping, Xiong Guoliang, Yang Shudong, Li Shunmin
Department of Nephrology, Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.
Shenzhen Key Laboratory of Hospital Chinese Medicine Preparation, Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.
Evid Based Complement Alternat Med. 2020 Oct 10;2020:8524132. doi: 10.1155/2020/8524132. eCollection 2020.
Our previous studies have demonstrated that Jian-Pi-Yi-Shen formula (JPYSF), a traditional Chinese herbal decoction, has a renoprotective effect in 5/6 nephrectomy-induced chronic kidney injury. However, the role and potential mechanisms of JPYSF in the treatment of acute kidney injury (AKI) remain unknown. This study was designed to test the beneficial effect of JPYSF in an AKI mouse model and to investigate the underlying mechanism by using metabolomics analysis. The AKI mouse model was induced by a single intraperitoneal injection of cisplatin at a dose of 20 mg/kg. The mice in the treatment group were pretreated orally with JPYSF (18.35 g/kg/d) for 5 days before cisplatin injection. Seventy-two hours after cisplatin injection, serum and kidney samples were collected for biochemical and histological examination. Ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UHPLC-QTOF/MS) was applied to analyze metabolic profiling variations in the kidney. The results showed that pretreatment with JPYSF obviously reduced the levels of serum creatinine and blood urea nitrogen and alleviated renal pathological injury in AKI mice. Orthogonal partial least-squares discriminant analysis (OPLS-DA) score plot revealed a clear separation between the AKI and AKI + JPYSF group. A total of 68 and 87 significantly differentially expressed metabolites were identified in the kidney of AKI mice responding to JPYSF treatment in negative and positive ion mode, respectively. The pivotal pathways affected by JPYSF included vitamin B6 metabolism, alanine, aspartate and glutamate metabolism, lysine biosynthesis, and butanoate metabolism. In conclusion, JPYSF can protect the kidney from cisplatin-induced AKI, which may be associated with regulating renal metabolic disorders.
我们之前的研究表明,中药复方煎剂健脾益肾方(JPYSF)对5/6肾切除诱导的慢性肾损伤具有肾脏保护作用。然而,JPYSF在急性肾损伤(AKI)治疗中的作用及潜在机制尚不清楚。本研究旨在测试JPYSF在AKI小鼠模型中的有益作用,并通过代谢组学分析探讨其潜在机制。AKI小鼠模型通过腹腔注射20mg/kg顺铂诱导。治疗组小鼠在注射顺铂前5天口服JPYSF(18.35g/kg/d)进行预处理。顺铂注射72小时后,收集血清和肾脏样本进行生化和组织学检查。采用超高效液相色谱-四极杆飞行时间质谱联用技术(UHPLC-QTOF/MS)分析肾脏代谢谱变化。结果表明,JPYSF预处理明显降低了AKI小鼠的血清肌酐和血尿素氮水平,减轻了肾脏病理损伤。正交偏最小二乘法判别分析(OPLS-DA)得分图显示AKI组和AKI+JPYSF组之间有明显分离。在负离子模式和正离子模式下,分别在接受JPYSF治疗的AKI小鼠肾脏中鉴定出68种和87种显著差异表达的代谢物。受JPYSF影响的关键途径包括维生素B6代谢、丙氨酸、天冬氨酸和谷氨酸代谢、赖氨酸生物合成和丁酸代谢。总之,JPYSF可以保护肾脏免受顺铂诱导的AKI,这可能与调节肾脏代谢紊乱有关。